Sunlink Health Systems Stock Fundamentals
| SSY Stock | USD 0.87 0.01 1.16% |
SunLink Health Systems fundamentals help investors to digest information that contributes to SunLink Health's financial success or failures. It also enables traders to predict the movement of SunLink Stock. The fundamental analysis module provides a way to measure SunLink Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SunLink Health stock.
At this time, SunLink Health's Depreciation And Amortization is fairly stable compared to the past year. Net Interest Income is likely to rise to about 97.7 K in 2024, despite the fact that Interest Expense is likely to grow to (855.00). SunLink | Select Account or Indicator |
SunLink Health Systems Company Return On Equity Analysis
SunLink Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current SunLink Health Return On Equity | -0.14 |
Most of SunLink Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SunLink Health Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
SunLink Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, SunLink Health Systems has a Return On Equity of -0.1384. This is 99.42% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 55.35% lower than that of the firm.
SunLink Health Systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SunLink Health's current stock value. Our valuation model uses many indicators to compare SunLink Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SunLink Health competition to find correlations between indicators driving SunLink Health's intrinsic value. More Info.SunLink Health Systems is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . At this time, SunLink Health's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SunLink Health's earnings, one of the primary drivers of an investment's value.SunLink Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SunLink Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SunLink Health could also be used in its relative valuation, which is a method of valuing SunLink Health by comparing valuation metrics of similar companies.SunLink Health is currently under evaluation in return on equity category among its peers.
SunLink Fundamentals
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0687 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | (549.86 K) | ||||
| Shares Outstanding | 7.04 M | ||||
| Shares Owned By Insiders | 26.60 % | ||||
| Shares Owned By Institutions | 13.46 % | ||||
| Number Of Shares Shorted | 25.58 K | ||||
| Price To Earning | 3.06 X | ||||
| Price To Book | 0.38 X | ||||
| Price To Sales | 0.19 X | ||||
| Revenue | 32.44 M | ||||
| Gross Profit | 4.71 M | ||||
| EBITDA | (455 K) | ||||
| Net Income | (1.53 M) | ||||
| Cash And Equivalents | 4.49 M | ||||
| Cash Per Share | 0.97 X | ||||
| Total Debt | 528 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 2.19 X | ||||
| Book Value Per Share | 2.27 X | ||||
| Cash Flow From Operations | (2.98 M) | ||||
| Short Ratio | 2.98 X | ||||
| Earnings Per Share | (0.33) X | ||||
| Target Price | 2.35 | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 6.09 M | ||||
| Total Asset | 20.61 M | ||||
| Retained Earnings | 1.48 M | ||||
| Working Capital | 11.45 M | ||||
| Current Asset | 17.89 M | ||||
| Current Liabilities | 20.05 M | ||||
| Net Asset | 20.61 M |
About SunLink Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SunLink Health Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SunLink Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SunLink Health Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 18 K | 17.1 K | |
| Total Revenue | 32.4 M | 30.8 M | |
| Cost Of Revenue | 19.5 M | 18.6 M | |
| Sales General And Administrative To Revenue | 0.34 | 0.12 | |
| Capex To Revenue | 0.05 | 0.02 | |
| Revenue Per Share | 4.61 | 8.72 | |
| Ebit Per Revenue | (0.07) | (0.02) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SunLink Stock Analysis
When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.